[Comparative studies of the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia].
In order to evaluate the influence of some neuroleptics on unproductive symptoms of schizophrenic process, first hospitalized patients with paranoid schizophrenia underwent monotherapy with perazine, fluphenazine, trifluoroperazine, chlorpromazine, and haloperidol. All the drugs eliminated the productive activity of the disease process within 2 months in both women and men aged 18-40 years. However, drugs showed different qualitative and quantitative effects on unproductive symptoms of schizophrenic process; this fact allows the suggestion regarding the particular usefulness of drugs in the out-patient care.
Termińska
K
K
Mrowiec
W
W
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002746:Chlorpromazine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D005476:Fluphenazine / Q000627:therapeutic use; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010464:Perazine / Q000627:therapeutic use; D012563:Schizophrenia, Paranoid / Q000188:drug therapy*; D014268:Trifluoperazine / Q000627:therapeutic use
D014150:Antipsychotic Agents; D014268:Trifluoperazine; D010464:Perazine; D006220:Haloperidol; D005476:Fluphenazine; D002746:Chlorpromazine
Badanie porównawcze wpływu perazyny, flufenazyny, trifluoroperazyny, chloropromazny i haloperydolu na objawy pierwotne i deficytowe pierwszego zachorowania na schizofrenie paranoidalna.